Paper42650737
A Novel Antimicrobial Peptide Displaying Broad-Spectrum Activity Against Pan-Resistant Pathogens and Low Propensity for Resistance Development.
Temur BZ and 7 others. Antibiotics (Basel), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. A Novel Antimicrobial Peptide Displaying Broad-Spectrum Activity Against Pan-Resistant Pathogens and Low Propensity for Resistance Development. Papers, record 42650737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42650737
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Novel Antimicrobial Peptide Displaying Broad-Spectrum Activity Against Pan-Resistant Pathogens and Low Propensity for Resistance Development.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 119C036 | Türkiye Bilimsel ve Teknolojik Araştırma Kurumu | PubMed | ||
| 217S060 | Türkiye Bilimsel ve Teknolojik Araştırma Kurumu | PubMed |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32117132 | Resistance Evolution Against Antimicrobial Peptides in Staphylococcus aureus Alters Pharmacodynamics Beyond the MIC. | Front Microbiol | 2020 | https://conductscience.org/library/papers/32117132 | PubMed |
| 2 | 36980322 | Antibiotic Resistance Diagnosis in ESKAPE Pathogens-A Review on Proteomic Perspective. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/36980322 | PubMed |
| 3 | 35065702 | Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. | Lancet | 2022 | https://conductscience.org/library/papers/35065702 | PubMed |
| 4 | 31191496 | YhjX Regulates the Growth of Escherichia coli in the Presence of a Subinhibitory Concentration of Gentamicin and Mediates the Adaptive Resistance to Gentamicin. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31191496 | PubMed |
| 5 | 31385762 | Antiviral Activities of Human Host Defense Peptides. | Curr Med Chem | 2020 | https://conductscience.org/library/papers/31385762 | PubMed |
| 6 | 34684258 | Bacterial Antibiotic Resistance: The Most Critical Pathogens. | Pathogens | 2021 | https://conductscience.org/library/papers/34684258 | PubMed |
| 7 | 39475864 | In vitro antibacterial activity of Morinda citrifolia extracts against eight pathogenic bacteria species. | PLoS One | 2024 | https://conductscience.org/library/papers/39475864 | PubMed |
| 8 | 21793988 | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. | Clin Microbiol Infect | 2012 | https://conductscience.org/library/papers/21793988 | PubMed |
| 9 | 11168187 | EUCAST Definitive Document E.DEF 3.1, June 2000: Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. | Clin Microbiol Infect | 2000 | https://conductscience.org/library/papers/11168187 | PubMed |
| 10 | 40118976 | Antimicrobial activity of cephamycins and β-lactam/β-lactamase inhibitors against ESBL-producing Escherichia coli and Klebsiella pneumoniae under standard and high bacterial inocula. | Sci Rep | 2025 | https://conductscience.org/library/papers/40118976 | PubMed |
| 11 | 40260375 | Global trends in antimicrobial resistance of Enterococcus faecium: a systematic review and meta-analysis of clinical isolates. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40260375 | PubMed |
| 12 | 32257965 | Antifungal Peptides as Therapeutic Agents. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/32257965 | PubMed |
| 13 | 22421877 | Modulating immunity as a therapy for bacterial infections. | Nat Rev Microbiol | 2012 | https://conductscience.org/library/papers/22421877 | PubMed |
| 14 | 31941022 | Development and Challenges of Antimicrobial Peptides for Therapeutic Applications. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/31941022 | PubMed |
| 15 | 28273381 | Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence. | Pharmacotherapy | 2017 | https://conductscience.org/library/papers/28273381 | PubMed |
| 16 | 39254296 | Synergistic antimicrobial combination of third-generation cephalosporins and polymyxin B against carbapenem-polymyxin-resistant Klebsiella pneumoniae: an in vitro and in vivo analysis. | Antimicrob Agents Chemother | 2024 | https://conductscience.org/library/papers/39254296 | PubMed |
| 17 | 36290075 | Antimicrobial Peptides-Mechanisms of Action, Antimicrobial Effects and Clinical Applications. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36290075 | PubMed |
| 18 | 39894233 | Novel antibacterial agents and emerging therapies in the fight against multidrug-resistant Acinetobacter baumannii. | Microb Pathog | 2025 | https://conductscience.org/library/papers/39894233 | PubMed |
| 19 | 33106260 | Systematic Investigation of Resistance Evolution to Common Antibiotics Reveals Conserved Collateral Responses across Common Human Pathogens. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/33106260 | PubMed |
| 20 | 21573784 | Multifunctional cationic host defence peptides and their clinical applications. | Cell Mol Life Sci | 2011 | https://conductscience.org/library/papers/21573784 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42650737
GET https://conductscience.org/api/papers/v1/42650737/references?page=2